Cargando…

Procalcitonin Increase Is Associated with the Development of Critical Care-Acquired Infections in COVID-19 ARDS

Secondary bacterial infection in COVID-19 patients is associated with increased mortality and disproportionately affects critically ill patients. This single-centre retrospective observational study investigates the comparative efficacy of change in procalcitonin (PCT) and other commonly available b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Richards, Owen, Pallmann, Philip, King, Charles, Cheema, Yusuf, Killick, Charlotte, Thomas-Jones, Emma, Harris, Jessica, Bailey, Catherine, Szakmany, Tamas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615001/ https://www.ncbi.nlm.nih.gov/pubmed/34827363 http://dx.doi.org/10.3390/antibiotics10111425

Ejemplares similares

Differences in Inflammatory Marker Kinetics between the First and Second Wave of COVID-19 Patients Admitted to the ICU: A Retrospective, Single-Center Study
por: Szakmany, Tamas, et al.
Publicado: (2021)

Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational study
por: Sinha, Pratik, et al.
Publicado: (2020)

Redefining ARDS: a paradigm shift
por: Villar, Jesús, et al.
Publicado: (2023)

Use of Procalcitonin during the First Wave of COVID-19 in the Acute NHS Hospitals: A Retrospective Observational Study
por: Powell, Neil, et al.
Publicado: (2021)

Procalcitonin Evaluation of Antibiotic Use in COVID-19 Hospitalised Patients (PEACH): Protocol for a Retrospective Observational Study
por: Euden, Joanne, et al.
Publicado: (2022)

P14 Procalcitonin evaluation of antibiotic use in COVID-19 hospitalized patients during the first wave of COVID-19: the PEACH study
por: Euden, Joanne, et al.
Publicado: (2022)

Is there a role of extravascular lung water (EVLW) in the development of atelectasis in ARDS?
por: Szakmány, T, et al.
Publicado: (2003)

Procalcitonin in the critically ill
por: Kazda, A, et al.
Publicado: (2005)

The role of rotational thromboelastometry in understanding the coagulation problems in COVID-19 associated critical illness
por: Duric, Natalie, et al.
Publicado: (2021)

Role of procalcitonin in diagnosis of community acquired pneumonia in Children
por: Ratageri, Vinod H., et al.
Publicado: (2022)

Extravascular lung water (EVLW) does not change during alveolar recruitment in acute respiratory distress syndrome (ARDS)
por: Toth, I, et al.
Publicado: (2004)

The effect of vitamin C on procalcitonin biomarker in community‐acquired pneumonia
por: Nikzad, Mahsa, et al.
Publicado: (2021)

ROLE OF PROCALCITONIN IN PATIENTS WITH COVID-19 AND HOSPITAL-ACQUIRED PNEUMONIA
por: KUMAR, MYTHRI ANIL, et al.
Publicado: (2022)

Herpesviruses in Critically Ill Patients With ARDS
por: Hraiech, Sami, et al.
Publicado: (2022)

Kinetics of C-Reactive Protein and Procalcitonin in the Early Identification of ICU-Acquired Infections in Critically Ill COVID-19 Patients
por: Cidade, José Pedro, et al.
Publicado: (2023)

Procalcitonin: a prognostic marker for critically ill
por: Bhattacharyya, M, et al.
Publicado: (2009)

Is Procalcitonin Useful in Pediatric Critical Care Patients?
por: Bobillo-Perez, Sara, et al.
Publicado: (2018)

Severe community acquired pneumonia and ARDS: prognostic factors in infants
por: Chidini, G, et al.
Publicado: (2003)

Procalcitonin Values Fail to Track the Presence of Secondary Bacterial Infections in COVID-19 ICU Patients
por: Harte, Elsa, et al.
Publicado: (2023)

Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia
por: Self, Wesley H., et al.
Publicado: (2017)

Procalcitonin and CRP as Biomarkers in Discrimination of Community-acquired Pneumonia and Exacerbation of COPD
por: Çolak, Ayfer, et al.
Publicado: (2017)

Patterns of Healthcare Resource Utilisation of Critical Care Survivors between 2006 and 2017 in Wales: A Population-Based Study
por: Alsallakh, Mohammad, et al.
Publicado: (2023)

Discrete-Event Simulation Modeling of Critical Care Flow: New Hospital, Old Challenges
por: Williams, Elizabeth, et al.
Publicado: (2020)

Impact of introducing procalcitonin testing on antibiotic usage in acute NHS hospitals during the first wave of COVID-19 in the UK: a controlled interrupted time series analysis of organization-level data—authors’ response
por: Llewelyn, Martin J, et al.
Publicado: (2022)

Diagnostic accuracy of procalcitonin in critically ill immunocompromised patients
por: Bele, Nicolas, et al.
Publicado: (2011)

In critically ill patients the procalcitonin level can be misleading
por: Koeze, Jacqueline, et al.
Publicado: (2011)

Procalcitonin as a marker of infection in critically ill patients
por: Koukiasa, P, et al.
Publicado: (2004)

Usefulness of Plasma Procalcitonin to Predict Severity in Elderly Patients with Community-Acquired Pneumonia
por: Kim, Ji Hye, et al.
Publicado: (2013)

CON: Procalcitonin does not have clinical utility in children with community-acquired pneumonia
por: Banerjee, Ritu
Publicado: (2021)

A methodology to facilitate critical care research using multiple linked electronic, clinical and administrative health records at population scale
por: Griffiths, Rowena, et al.
Publicado: (2022)

Prolonged Glucocorticoid Treatment in ARDS: Impact on Intensive Care Unit-Acquired Weakness
por: Meduri, Gianfranco Umberto, et al.
Publicado: (2016)

The Association of Procalcitonin and C-Reactive Protein with Bacterial Infections Acquired during Intensive Care Unit Stay in COVID-19 Critically Ill Patients
por: Campani, Simone, et al.
Publicado: (2023)

Procalcitonin to Guide Antibiotic Therapy for Critically Ill Patients in Korea
por: Park, Seong Yeon
Publicado: (2019)

Procalcitonin Predicts Response to Beta-Lactam Treatment in Hospitalized Children with Community-Acquired Pneumonia
por: Cohen, Jérémie F., et al.
Publicado: (2012)

Interleukin-6 and procalcitonin as biomarkers in mortality prediction of hospitalized patients with community acquired pneumonia
por: Andrijevic, Ilija, et al.
Publicado: (2014)

Procalcitonin Accurately Identifies Hospitalized Children With Low Risk of Bacterial Community-Acquired Pneumonia
por: Stockmann, Chris, et al.
Publicado: (2018)

Value of procalcitonin as a biomarker for postoperative hospital-acquired pneumonia after abdominal surgery
por: Abu Elyazed, Mohamed M, et al.
Publicado: (2017)

P12 Antibiotic prescribing in hospitalized patients with COVID-19 as a function of inflammatory markers in Wave 1 versus Wave 2: a systematic review
por: Chatoo, Saif Abbas, et al.
Publicado: (2022)

Soluble Toll-like receptor 2 is a biomarker for sepsis in critically ill patients with multi-organ failure within 12 h of ICU admission
por: Holst, Benjamin, et al.
Publicado: (2017)

Procalcitonin metabolomics in the critically ill reveal relationships between inflammation intensity and energy utilization pathways
por: Kobayashi, Hirotada, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fllqsqpnot2v53485c8k38c7ot